Wipro gains on entering into strategic partnership with Takeda Pharmaceutical

Wipro is currently trading at Rs. 492.00, up by 10.50 points or 2.18% from its previous closing of Rs. 481.50 on the BSE. The scrip opened at Rs. 486.00 and has touched a high and low of Rs. 492.30 and Rs. 485.55 respectively. So far 29,000 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 610.50 on 26-Feb-2014 and a 52 week low of Rs. 315.30 on 31-May-2013. Last one week high and low of the scrip stood at Rs. 531.95 and Rs. 475.35 respectively. The current market cap of the company is Rs. 1,21,375.90 crore. The promoters holding in the company stood at 73.47% while Institutions and Non-Institutions held 13.62% and 10.97% respectively. Wipro has entered into strategic partnership with Takeda Pharmaceutical Company, the largest pharmaceutical company in Japan and one of the global leaders of the Industry. This strategic partnership will build advanced value in Takeda’s operations by consolidating IT platforms across the organization. As a strategic partner, Wipro will build and maintain an ‘as-a-service’ global platform for Takeda that will drive synergies across its global entities through standardization of IT architecture. Wipro will be primary provider of IT Infrastructure management services covering Takeda's entities across the world, touching 30,000 users in 16 different languages, operating out of data centers in Asia, Europe and America. Wipro is a leading provider of analytics and information management solutions - enabling customers to derive actionable business insights from data to drive growth, enhance cost management and strengthen risk management.